MedtronicRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Medtronic (MDT) reported revenue of $9.81B in Q2 2026, with Cardiac and Vascular Group its largest revenue segment at 38%.
MedtronicMedtronic develops implantable and external devices across cardiovascular, neuroscience, and medical surgical portfolios. MiniMed, its diabetes business, completed an IPO on March 9, 2026 and remains consolidated while Medtronic retains control.
Medtronic (MDT) is a Health Care Equipment company. Medtronic develops implantable and external devices across cardiovascular, neuroscience, and medical surgical portfolios. MiniMed, its diabetes business, completed an IPO on March 9, 2026 and remains consolidated while Medtronic retains control. It was founded in 1949, is headquartered in Galway, Ireland and employs about 95,000 people.
As of 2026-Q1, Medtronic's revenue breaks down across Cardiac and Vascular Group (38%), Neuroscience Group (28%), Medical Surgical (24%), Diabetes Group (9%). See the revenue-by-segment chart for the full mix.
Track Medtronic's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated August 26, 2026.
Sterling groups Medtronic in the Healthcare sector, alongside Abbott Laboratories (ABT), Baxter International (BAX), Becton Dickinson (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW) and GE HealthCare (GEHC).
If you are researching Medtronic, also look at Abbott Laboratories (ABT), Baxter International (BAX) and Becton Dickinson (BDX). You can compare all of them side by side or browse the full Healthcare sector on Sterling.
Q3 2016-Q2 2026
Q3 2016-Q2 2026